CRISPR-Cas9 used to systematically inactivate genes in colorectal cancer
Researchers have used CRISPR-Cas9 to inactivate genes in human colorectal cancer cell lines -- one with normal KRAS gene and one with a mutant KRAS...
List view / Grid view
Researchers have used CRISPR-Cas9 to inactivate genes in human colorectal cancer cell lines -- one with normal KRAS gene and one with a mutant KRAS...
Drug Target Review welcomes Janusz Kulagowski to its advisory board ...
A new study from has shed light on just how viruses evolve so quickly and offers a potential way to slow them down...
Researchers find novel combination disrupts multiple factors in aggressive breast cancer...
Researchers have identified a new biomarker for chronic traumatic encephalopathy that may allow the disease to be diagnosed during life for the first time...
Researchers have developed a technique to produce synthetic steroids that could pave the way for a cascade of new drug discoveries...
Researchers have used a multi-modal integrated approach to develop potential new anti-Chagas therapies...
Paediatric researchers have identified common gene variants that raise the risk of an aggressive forms of childhood cancer...
NPL's new approach informed by government priorities, consultancy with industry and the NHS, and a century of expertise, will see it focus on some of the world’s biggest health challenges, from supporting the diagnosis and treatment of cancer and dementia, to reducing attrition rates in drug development, to creating new…
Researchers have tested a new MRI contrast agent that pinpoints breast cancers at early stages and differentiates between aggressive and slow-growing types...
Researchers have identified exosomes as the missing link in diabetes...
Scientists have designed a synthetic molecule bryostatin-1 that can reactivate dormant HIV...
Researchers have used genome editing technology to reveal the role of a key gene in human embryos in the first few days of development...
Researchers have identified that the presence of ApoE4 exacerbates the brain damage caused by toxic tangles of tau protein...
Depletion of B cells in the tumour micro-environment shows anti-tumour activity in patients with advanced metastatic melanoma...